Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07576946 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The SATURİSTA Device

Study acronym: SATURİSTA
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 8, 2026 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Minor Study First Submitted
47 trials monitored
See 1 trial at risk
This study aims to evaluate the functional performance and feasibility of the Saturista system, a novel device designed for automated oxygen flow regulation based on continuous monitoring of oxygen saturation (SpO₂). The system integrates real-time physiological monitoring, wireless data transmission, and centralized visualization to support timely detection of oxygen desaturation and clinical decision-making. A pilot feasibility study will be conducted in healthy volunteers using a scenario-based protocol, including baseline monitoring, controlled desaturation, probe disconnection, and signal recovery. The primary objective is to assess the system's ability to generate alarms in response to changes in SpO₂ and to display data in real time. Secondary objectives include evaluation of response time, signal management, and overall system stability.
Trial Details
NCT Number NCT07576946
Lead Sponsor Koç University
Collaborators: Health Institutes of Turkey, Istinye University
Conditions
(from sponsor)
Oxygen Therapy
Enrollment 7 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov